News

The Lancet1h
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles
The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...
Vir announces 24-week post-end of treatment data for Hep B therapy
Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...
The Alpena News19h
Health officials urge people to get tested, learn more during Hepatitis Awareness Month
May is Hepatitis Awareness Month, and the Michigan Department of Health and Human Services (MDHHS) is encouraging Michigan ...
Fierce Biotech11d
Vir's 'functional cure' candidate for hepatitis B misses mark in phase 2
Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...
Onlymyhealth1d
Hepatitis Testing Day 2025: What Is The Difference Between Hepatitis B And Jaundice?
On Hepatitis Testing Day 2025 learn how Hepatitis B differs from jaundice Understand their causes symptoms and treatments and why timely diagnosis is crucial Read on to know more!
Northwest Asian Weekly4d
Hepatitis B: Knowledge and Prevention
According to the Hepatitis B Foundation, up to 2.4 million people in the United States are living with chronic hepatitis B ...
Pharmabiz4d
Excision announces publication highlighting EBT-107 for treatment of chronic hepatitis B in bioRxiv
Excision announces publication highlighting EBT-107 for treatment of chronic hepatitis B in bioRxiv: Watertown, Massachusetts Friday, May 16, 2025, 18:00 Hrs [IST] Excision BioThe ...